Traders bought shares of CVS Health Corporation (NYSE:CVS) on weakness during trading on Thursday. $94.21 million flowed into the stock on the tick-up and $57.62 million flowed out of the stock on the tick-down, for a money net flow of $36.59 million into the stock. Of all equities tracked, CVS Health Corporation had the 9th highest net in-flow for the day. CVS Health Corporation traded down ($0.56) for the day and closed at $95.50

Several equities research analysts have issued reports on the company. FBR & Co reissued a “buy” rating on shares of CVS Health Corporation in a research note on Saturday, May 14th. Zacks Investment Research cut CVS Health Corporation from a “hold” rating to a “sell” rating in a research note on Monday, April 18th. Macquarie reaffirmed an “outperform” rating and issued a $115.00 price objective on shares of CVS Health Corporation in a research note on Thursday, May 5th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $115.00 price objective (up from $110.00) on shares of CVS Health Corporation in a research note on Wednesday, May 4th. Finally, Mizuho reaffirmed a “buy” rating and issued a $117.00 price objective (up from $104.00) on shares of CVS Health Corporation in a research note on Wednesday, May 4th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, seventeen have given a buy rating and two have assigned a strong buy rating to the company. CVS Health Corporation presently has a consensus rating of “Buy” and an average target price of $113.72.

The stock’s 50-day moving average is $95.96 and its 200 day moving average is $98.37. The company has a market cap of $102.57 billion and a PE ratio of 20.76.

CVS Health Corporation (NYSE:CVS) last announced its earnings results on Tuesday, May 3rd. The pharmacy operator reported $1.18 earnings per share for the quarter, beating the consensus estimate of $1.16 by $0.02. During the same quarter in the prior year, the business earned $1.14 earnings per share. The business had revenue of $43.20 billion for the quarter, compared to analyst estimates of $43.01 billion. The firm’s revenue was up 18.9% on a year-over-year basis. On average, equities analysts expect that CVS Health Corporation will post $5.83 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, August 1st. Stockholders of record on Thursday, July 21st will be paid a dividend of $0.425 per share. The ex-dividend date is Tuesday, July 19th. This represents a $1.70 annualized dividend and a dividend yield of 1.78%.

In other news, CEO Larry J. Merlo sold 38,247 shares of the firm’s stock in a transaction dated Thursday, May 5th. The stock was sold at an average price of $105.00, for a total transaction of $4,015,935.00. Following the completion of the sale, the chief executive officer now directly owns 280,381 shares in the company, valued at $29,440,005. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Troyen A. Brennan sold 7,517 shares of the firm’s stock in a transaction dated Thursday, May 5th. The shares were sold at an average price of $105.00, for a total value of $789,285.00. Following the sale, the executive vice president now owns 69,601 shares of the company’s stock, valued at $7,308,105. The disclosure for this sale can be found here.

Several hedge funds have made changes to their positions in the stock. Brown Advisory Securities LLC increased its stake in shares of CVS Health Corporation by 14.8% in the fourth quarter. Brown Advisory Securities LLC now owns 10,306 shares of the pharmacy operator’s stock valued at $1,006,000 after buying an additional 1,331 shares in the last quarter. Strategic Advisors LLC boosted its position in shares of CVS Health Corporation by 1.5% in the fourth quarter. Strategic Advisors LLC now owns 10,401 shares of the pharmacy operator’s stock valued at $1,017,000 after buying an additional 151 shares during the last quarter. NEXT Financial Group Inc boosted its position in shares of CVS Health Corporation by 1.5% in the fourth quarter. NEXT Financial Group Inc now owns 10,611 shares of the pharmacy operator’s stock valued at $1,037,000 after buying an additional 155 shares during the last quarter. Sawtooth Asset Management Inc. boosted its position in shares of CVS Health Corporation by 96.0% in the fourth quarter. Sawtooth Asset Management Inc. now owns 10,624 shares of the pharmacy operator’s stock valued at $1,039,000 after buying an additional 5,203 shares during the last quarter. Finally, Checchi Capital Advisers LLC boosted its position in shares of CVS Health Corporation by 9.0% in the fourth quarter. Checchi Capital Advisers LLC now owns 10,701 shares of the pharmacy operator’s stock valued at $1,046,000 after buying an additional 882 shares during the last quarter.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.